Skip to content
Wednesday, 4 November 2026
Inspire.News

Unveiling truth, one story at a time

Africa’s first-ever Phase 1 trial of long-acting injectable for malaria prevention launches in Rwanda

From The Sun Nigeria 1 min read
Save
Africa’s first-ever Phase 1 trial of long-acting injectable for malaria prevention launches in Rwanda
Image: The Sun Nigeria
Full coverage See how 2 outlets are reporting this story →

Medicines for Malaria Venture (MMV) ‎and Rinda Ubuzima, a leading Rwandan health research organization, today announced the launch of a Phase 1b clinical trial for a potential long-acting injectable (LAI) for malaria prevention. The post Africa’s first-ever Phase 1 trial of long-acting injectable for malaria prevention launches in Rwanda appeared first on The Sun Nigeria.

Full story

Continue reading this story on The Sun Nigeria, the publisher that reported it.

Read the full story at The Sun Nigeria ↗

AI tools

Written by AI from the article text. It can make mistakes; check the original story.

Topics in this story

More from National · Nigeria

See all